U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Morbidity and Mortality Weekly Report (MMWR)

CDC Stacks Public Health Publications

The Morbidity and Mortality Weekly Report (MMWR) series are CDC’s primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. The MMWR series includes the following publications: MMWR Weekly, MMWR Recommendations and Reports, CDC Surveillance Summaries and MMWR Supplements. These journals are freely available to the public as Diamond Open Access. For more on MMWR, visit https://www.cdc.gov/mmwr/index.html.

(45)
(67)
(184)
(229)
(500)
(673)
(659)
(403)
(489)
(557)
(246)
(325)
(427)
(406)
(97)
(156)
(103)
(110)
(97)
(92)
(119)
(92)
(108)
(96)
(97)
(92)
(79)
(97)
(87)
(91)
(88)
(76)
(74)
(84)
(80)
(69)
(70)
(73)
(68)
(69)
(59)
(67)
(62)
(64)
(62)
(66)
(72)
(55)
(53)
(55)
(60)
(56)
(58)
(54)
(53)
(56)
(55)
(52)
(54)
(53)
(54)
(54)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(51)
0 of 75
(44)
(63)
(187)
(222)
(500)
(663)
(656)
(409)
(483)
(558)
(231)
(311)
(436)
(413)
(91)
(148)
(100)
(104)
(102)
(92)
(120)
(92)
(104)
(97)
(97)
(91)
(80)
(97)
(86)
(90)
(87)
(76)
(75)
(84)
(80)
(69)
(69)
(71)
(69)
(64)
(60)
(68)
(62)
(62)
(62)
(67)
(72)
(56)
(55)
(54)
(59)
(57)
(58)
(54)
(53)
(55)
(55)
(55)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(53)
(53)
(53)
(54)
(54)
(53)
(53)
(53)
(53)
(54)
0 of 75
(1)
(7)
(33)
(71)
(44)
(137)
(157)
(161)
(151)
(137)
(163)
(169)
(155)
(160)
(161)
(157)
(163)
(164)
(156)
(164)
(156)
(173)
(142)
(155)
(159)
(134)
(156)
(141)
(142)
(141)
(137)
(138)
(142)
(131)
(162)
(144)
(136)
(152)
(152)
(177)
(206)
(197)
(164)
(187)
(179)
(201)
(205)
(202)
(223)
(225)
(232)
(221)
(225)
(252)
(252)
(277)
0 of 56
(2)
(1)
(4)
(1)
(431)
(107)
(405)
(13)
(8547)
0 of 9
(16)
(34)
(37)
(4)
(1)
(2)
(6)
(1)
0 of 8
(10)
(10)
(25)
(11)
(7)
(20)
(27)
(42)
(58)
(7)
(23)
(13)
(7)
(38)
(10)
(10)
(50)
(7)
(33)
(1236)
(23)
(1293)
(32)
(71)
(10)
(91)
(26)
(16)
(7)
(791)
(198)
(24)
(128)
(70)
(39)
(61)
(10)
(9)
(11)
(17)
(20)
(38)
(19)
(26)
(15)
(26)
(9)
(11)
(17)
(10)
(7)
(48)
(11)
(8)
(223)
(17)
(17)
(8)
(181)
(137)
(129)
(32)
(8)
(15)
(13)
(9)
(10)
(13)
(15)
(9)
(15)
(8)
(29)
(17)
(10)
(7)
(18)
(100)
(13)
(12)
(36)
(18)
(8)
(12)
(7)
(11)
(11)
(30)
(9)
(9)
(9)
(15)
(21)
(8)
(17)
(7)
(8)
(31)
(77)
(10)
(61)
(7)
(7)
(14)
(12)
(13)
(15)
(19)
(85)
(13)
(11)
(14)
(31)
(14)
(13)
(30)
(28)
(12)
(187)
(7)
(7)
(17)
(8)
(18)
(53)
(11)
(7)
(17)
(22)
(20)
(7)
(15)
(10)
(9)
(24)
(13)
(31)
(20)
(29)
(7)
(13)
(13)
(31)
(73)
(10)
(21)
(24)
(8)
(26)
(20)
(7)
(7)
(8)
(13)
(28)
(25)
(9)
(940)
(740)
(9)
(14)
(7)
(14)
(35)
(7)
(103)
(10)
(51)
(10)
(19)
(11)
(11)
(9)
(58)
(12)
(20)
(14)
(49)
(20)
(21)
(19)
(20)
(16)
(177)
(80)
(2979)
(37)
(12)
(546)
(316)
(260)
(215)
(24)
(38)
(14)
(15)
(14)
(12)
(34)
(10)
(80)
(14)
(11)
(8)
(23)
(8)
(8)
(28)
(446)
(21)
(23)
(15)
(8)
(74)
(25)
(19)
(9)
(18)
(18)
(18)
(45)
(687)
(8)
(10)
(15)
(59)
(205)
(7)
(10)
(18)
(8)
(12)
(66)
(24)
(14)
(40)
(73)
(8)
(11)
(8)
(11)
(20)
(19)
(23)
(58)
(9)
(8)
(16)
(33)
(44)
(82)
(9)
(10)
(8)
(21)
(65)
(8)
(13)
(14)
(28)
(25)
(14)
(10)
(10)
(8)
(166)
(24)
(14)
(35)
(26)
(9)
(11)
(9)
(24)
(26)
(12)
(92)
(4170)
(636)
(34)
(12)
(17)
(10)
(14)
(11)
(12)
(13)
(9)
(28)
(16)
(19)
(8)
(8)
(12)
(27)
(17)
(14)
(44)
(20)
(28)
(36)
(10)
(20)
(8)
(21)
(8)
(66)
(91)
(24)
(9)
(27)
(13)
(21)
(22)
(8)
(39)
(56)
(68)
(21)
(15)
(149)
(8)
(12)
(32)
(16)
(14)
(19)
(19)
(16)
(22)
(10)
(11)
(144)
(45)
(32)
(9)
(41)
(32)
(15)
(654)
(51)
(26)
(9)
(56)
(14)
(130)
(9)
(18)
(62)
(8)
(10)
(10)
(30)
(11)
(10)
(13)
(21)
(8)
(15)
(23)
(111)
(23)
(1338)
(14)
(10)
(17)
(11)
(13)
(8)
(8)
(48)
(8)
(25)
(186)
(14)
(42)
(45)
(25)
(47)
(13)
(16)
(11)
(593)
(394)
(15)
(21)
(14)
(152)
(15)
(53)
(9)
(28)
(10)
(19)
(11)
(8)
(8)
(110)
(10)
(78)
(11)
(52)
(68)
(59)
(17)
(23)
(60)
(132)
(19)
(105)
(58)
(12)
(39)
(126)
(35)
(97)
(17)
(10)
(11)
(12)
(12)
(8)
(14)
(52)
(69)
(116)
(29)
(172)
(25)
(17)
(50)
(12)
(10)
(33)
(12)
(10)
(45)
(11)
(8)
(8)
(60)
(31)
(90)
(44)
(19)
(159)
(10)
(14)
(31)
(8)
(8)
(9)
(9)
(12)
(28)
(51)
(9)
(206)
(18)
(31)
(17)
(19)
(2445)
(16)
(18)
(18)
(11)
(104)
(20)
(38)
(8)
(206)
(231)
(23)
(8)
(8)
(9)
(18)
(240)
(11)
(49)
(678)
(10)
(307)
(15)
(47)
(61)
(23)
(17)
(8)
(21)
(595)
(13)
(61)
(15)
(14)
(9)
(37)
(26)
(22)
(29)
(188)
(45)
(54)
(48)
(8)
(114)
(50)
(10)
(125)
(28)
(11)
(12)
(8)
(32)
(22)
(8)
(12)
(8)
(22)
(13)
(61)
(16)
(11)
(10)
(73)
(9)
(10)
(10)
(74)
(32)
(114)
(9)
(13)
(41)
(17)
(55)
(17)
(13)
(16)
(18)
(10)
(17)
(44)
(66)
(10)
(11)
(9)
(10)
(177)
(17)
(12)
(14)
(1181)
(9)
(9)
(8)
(50)
(10)
(44)
(109)
(10)
(16)
(8)
(19)
(308)
(40)
(33)
(23)
(11)
(12)
(9)
(83)
(11)
(12)
(18)
(20)
(8)
(11)
(8)
(8)
(19)
(58)
(32)
(82)
(14)
(37)
(8)
(21)
(40)
(13)
(17)
(17)
(9)
(9)
(66)
(19)
(963)
(103)
(15)
(48)
(30)
(12)
(8)
(10)
(57)
(3831)
(11)
(9)
(9)
(31)
(16)
(21)
(16)
(16)
(15)
(17)
(10)
(13)
(8)
(8)
(11)
(18)
(9)
(14)
(15)
(9)
(16)
(41)
(43)
(20)
(10)
(27)
(11)
(12)
(10)
(15)
(243)
(18)
(22)
(8)
(36)
(14)
(113)
(10)
(257)
(611)
(72)
(11)
(21)
(17)
(8)
(11)
(15)
(9)
(10)
(299)
(12)
(10)
(8)
(14)
(11)
(12)
(11)
(20)
(10)
(10)
(16)
(13)
(13)
(10)
(22)
(10)
(65)
(10)
(9)
(10)
(9)
(9)
(19)
(12)
(9)
(144)
(18)
(14)
(8)
(33)
(144)
(11)
(171)
(10)
(8)
(8)
(22)
(70)
(343)
(114)
(84)
(24)
(36)
(34)
(11)
(30)
(14)
(8)
(10)
(25)
(21)
(29)
(21)
(18)
(16)
(1141)
(18)
(27)
(18)
(22)
(110)
(15)
(22)
(23)
(349)
(10)
(18)
(72)
(16)
(15)
(26)
(14)
(27)
(35)
(10)
(9)
(11)
(216)
(50)
(16)
(23)
(34)
(21)
(10)
(19)
(74)
(20)
(9)
(233)
(1003)
(22)
(24)
(71)
(101)
(2518)
(11)
(104)
(12)
(23)
(15)
(16)
(14)
(93)
(177)
(38)
(279)
(15)
(8)
(9)
(13)
(45)
(32)
(91)
(9)
(17)
(18)
(16)
(23)
(71)
(37)
(18)
(12)
(8)
(12)
(21)
(10)
(28)
(10)
(10)
(8)
(24)
(104)
(187)
(28)
(29)
(25)
(10)
(20)
(9)
(58)
(67)
(195)
(303)
(8)
(14)
(11)
(21)
(12)
(8)
(58)
(17)
(34)
(9)
(38)
(617)
(31)
(32)
(146)
(241)
(12)
(177)
(10)
(18)
(10)
(122)
(8)
(11)
(126)
(9)
(16)
(18)
(15)
(20)
(11)
(9)
(19)
(11)
(28)
(35)
(38)
(11)
(8)
(65)
(22)
(16)
(40)
(28)
(10)
(14)
(10)
(14)
(12)
(80)
(31)
(8)
(39)
(9)
(20)
(18)
(12)
(184)
(9)
(28)
(23)
(70)
(25)
(23)
(25)
(14)
(8)
(9)
(108)
(8)
(22)
(16)
(44)
(16)
(134)
(51)
(10)
(19)
(10)
(56)
(9)
(8)
(12)
(18)
(94)
(35)
(31)
(12)
(49)
(8)
(38)
(91)
(9)
(22)
(14)
(182)
(10)
(8)
(8)
(19)
(33)
(21)
(19)
(12)
(8)
(69)
(9)
(8)
(54)
(15)
(12)
(8)
(15)
(8)
(10)
(58)
(19)
(181)
(28)
(36)
(22)
(106)
(19)
(157)
(13)
(9)
(12)
(15)
(68)
(9)
(14)
(182)
(10)
(10)
(19)
(70)
(18)
(29)
(17)
(50)
(17)
(19)
(9)
(14)
(464)
(11)
(48)
(49)
(104)
(17)
(102)
(29)
(25)
(34)
(21)
(40)
(8)
(10)
(23)
(31)
(20)
(35)
(21)
(12)
(18)
(8)
(43)
(94)
(22)
(26)
(9)
(23)
(9)
(12)
(8)
(39)
(14)
(14)
(59)
(11)
(9)
(38)
(17)
(16)
(39)
(15)
(78)
(8)
(10)
(43)
(13)
(15)
(46)
(27)
(763)
(30)
(57)
(10)
(12)
(29)
0 of 1000
(12)
(12)
(15)
(7)
(23)
(9)
(7)
(18)
(8)
(7)
(10)
(11)
(7)
(9)
(7)
(10)
(9)
(11)
(11)
(19)
(9)
(11)
(9)
(10)
(27)
(8)
(9)
(12)
(23)
(15)
(9)
(7)
(7)
(7)
(9)
(13)
(11)
(9)
(15)
(7)
(7)
(7)
(7)
(9)
(8)
(19)
(9)
(9)
(7)
(7)
(13)
(7)
(7)
(9)
(7)
(9)
(7)
(16)
(13)
(7)
(12)
(12)
(22)
(28)
(15)
(8)
(8)
(13)
(7)
(19)
(12)
(12)
(13)
(15)
(16)
(9)
(10)
(7)
(11)
(28)
(7)
(13)
(28)
(7)
(10)
(11)
(11)
(13)
(10)
(8)
(18)
(9)
(10)
(16)
(29)
(8)
(12)
(12)
(13)
(8)
(9)
(7)
(28)
(9)
(16)
(7)
(29)
(7)
(8)
(8)
(11)
(16)
(16)
(12)
(35)
(8)
(11)
(16)
(18)
(9)
(29)
(9)
(14)
(22)
(31)
(11)
(7)
(7)
(10)
(7)
(18)
(9)
(7)
(9)
(7)
(7)
(7)
(11)
(9)
(23)
(20)
(10)
(7)
(7)
(15)
(10)
(8)
(37)
(8)
(22)
(10)
(16)
(11)
(10)
(24)
(13)
(7)
(11)
(7)
(9)
(11)
(9)
(12)
(21)
(9)
(9)
(7)
(11)
(7)
(16)
(9)
(7)
(9)
(12)
(19)
(12)
(7)
(7)
(7)
(11)
(10)
(7)
(9)
(24)
(7)
(8)
(10)
(12)
(8)
(13)
(25)
(23)
(7)
(24)
(16)
(9)
(7)
(10)
(9)
(8)
(8)
(13)
(9)
(9)
(10)
(7)
(10)
(7)
(20)
(8)
(9)
(7)
(18)
(17)
(11)
(10)
(12)
(9)
(12)
(7)
(9)
(7)
(9)
(8)
(15)
(8)
(8)
(13)
(28)
(7)
(18)
(8)
(12)
(15)
(7)
(7)
(17)
(17)
(8)
(16)
(8)
(20)
(7)
(8)
(11)
(11)
(21)
(8)
(11)
(10)
(13)
(9)
(8)
(7)
(12)
(8)
(15)
(9)
(11)
(7)
(17)
(12)
(17)
(16)
(7)
(18)
(24)
(11)
(7)
(7)
(12)
(8)
(19)
(20)
(16)
(11)
(12)
(7)
(8)
(10)
(14)
(16)
(7)
(9)
(11)
(20)
(15)
(9)
(16)
(48)
(9)
(11)
(24)
(11)
(8)
(9)
(7)
(10)
(9)
(7)
(10)
(8)
(53)
(13)
(9)
(11)
(15)
(42)
(16)
(8)
(8)
(29)
(10)
(7)
(10)
(8)
(8)
(24)
(8)
(11)
(12)
(8)
(13)
(21)
(24)
(10)
(10)
(16)
(20)
(11)
(10)
(15)
(17)
(12)
(18)
(7)
(17)
(16)
(10)
(15)
(18)
(14)
(16)
(22)
(7)
(9)
(17)
(12)
(15)
(8)
(18)
(20)
(15)
(11)
(29)
(7)
(10)
(23)
(7)
(7)
(27)
(8)
(7)
(26)
(18)
(8)
(12)
(11)
(8)
(36)
(15)
(12)
(7)
(8)
(15)
(16)
(7)
(7)
(9)
(10)
(9)
(17)
(7)
(12)
(12)
(13)
(12)
(16)
(9)
(13)
(8)
(15)
(24)
(8)
(8)
(8)
(7)
(17)
(9)
(7)
(28)
(12)
(15)
(13)
(9)
(7)
(7)
(9)
(8)
(7)
(8)
(14)
(9)
(14)
(17)
(7)
(8)
(7)
(10)
(11)
(7)
(16)
(9)
(59)
(12)
(8)
(8)
(7)
(7)
(9)
(7)
(18)
(7)
(8)
(18)
(9)
(15)
(10)
(8)
(25)
(11)
(8)
(9)
(14)
(26)
(23)
(8)
(43)
(11)
(14)
(7)
(15)
(11)
(20)
(7)
(28)
(15)
(10)
(9)
(25)
(18)
(7)
(8)
(8)
(7)
(18)
(15)
(15)
(11)
(7)
(8)
(7)
(10)
(14)
(8)
(30)
(15)
(7)
(9)
(19)
(18)
(15)
(9)
(7)
(7)
(8)
(13)
(11)
(15)
(17)
(8)
(49)
(7)
(32)
(13)
(10)
(16)
(7)
(23)
(24)
(9)
(10)
(25)
(8)
(20)
(7)
(7)
(13)
(7)
(11)
(9)
(7)
(7)
(10)
(9)
(8)
(9)
(7)
(7)
(10)
(16)
(14)
(12)
(7)
(10)
(20)
(9)
(15)
(7)
(7)
(11)
(12)
(11)
(13)
(8)
(7)
(19)
(26)
(17)
(7)
(15)
(9)
(8)
(18)
(17)
(8)
(8)
(12)
(7)
(10)
(7)
(9)
(8)
(18)
(18)
(11)
(8)
(35)
(21)
(7)
(7)
(18)
(9)
(7)
(10)
(7)
(10)
(9)
(14)
(14)
(10)
(24)
(12)
(8)
(53)
(7)
(7)
(7)
(19)
(8)
(10)
(10)
(8)
(10)
(7)
(9)
(8)
(8)
(20)
(13)
(27)
(8)
(8)
(19)
(7)
(19)
(7)
(11)
(7)
(12)
(7)
(11)
(11)
(28)
(10)
(9)
(7)
(20)
(10)
(13)
(7)
(8)
(9)
(13)
(11)
(10)
(7)
(13)
(9)
(7)
(10)
(8)
(7)
(7)
(10)
(14)
(9)
(38)
(23)
(10)
(8)
(7)
(10)
(11)
(10)
(13)
(15)
(10)
(7)
(17)
(10)
(7)
(7)
(11)
(11)
(12)
(8)
(10)
(18)
(14)
(8)
(10)
(21)
(16)
(14)
(14)
(9)
(15)
(9)
(19)
(24)
(11)
(20)
(21)
(16)
(7)
(7)
(10)
(23)
(7)
(8)
(17)
(7)
(9)
(10)
(7)
(7)
(17)
(8)
(8)
(7)
(9)
(9)
(13)
(10)
(8)
(13)
(9)
(13)
(8)
(18)
(7)
(7)
(27)
(12)
(8)
(15)
(9)
(17)
(8)
(18)
(7)
(26)
(12)
(9)
(11)
(22)
(7)
(10)
(7)
(7)
(13)
(7)
(7)
(8)
(10)
(21)
(15)
(14)
(35)
(18)
(7)
(7)
(7)
(8)
(21)
(16)
(24)
(24)
(18)
(8)
(7)
(18)
(12)
(7)
(7)
(13)
(25)
(7)
(8)
(12)
(11)
(19)
(7)
(27)
(18)
(10)
(10)
(8)
(12)
(7)
(7)
(7)
(10)
(7)
(7)
(10)
(16)
(12)
(10)
(7)
(18)
(7)
(25)
(10)
(15)
(10)
(18)
(24)
(13)
(16)
(9)
(19)
(13)
(26)
(16)
(18)
(8)
(10)
(8)
(10)
(14)
(7)
(10)
(7)
(13)
(7)
(7)
(11)
(17)
(15)
(13)
(13)
(13)
(8)
(33)
(8)
(11)
(11)
(8)
(11)
(12)
(21)
(10)
(9)
(12)
(23)
(8)
(11)
(14)
(8)
(19)
(11)
(8)
(8)
(11)
(9)
(8)
(11)
(10)
(8)
(8)
(14)
(13)
(10)
(16)
(9)
(30)
(11)
(11)
(10)
(14)
(23)
(8)
(9)
(12)
(11)
(10)
(8)
(8)
(9)
(20)
(17)
(12)
(10)
(8)
(18)
(13)
(17)
(11)
(9)
(29)
(10)
(9)
(13)
(11)
(8)
(29)
(13)
(13)
(9)
(11)
(40)
(8)
(10)
(12)
(14)
(8)
(13)
(16)
(9)
(12)
(8)
(9)
(11)
(8)
(9)
(40)
(10)
(9)
(20)
(17)
(8)
(24)
(13)
(10)
(24)
(9)
(18)
(20)
(9)
(9)
(8)
(8)
(29)
(15)
(8)
(73)
(9)
(38)
(8)
(23)
(10)
(24)
(9)
(12)
(9)
(8)
(10)
(12)
(11)
(8)
(22)
(9)
(13)
(10)
(16)
(8)
(9)
(13)
(17)
(11)
(8)
(12)
(15)
(9)
(9)
(13)
(9)
(8)
(20)
(14)
(32)
(9)
(16)
(10)
(10)
(10)
(12)
(8)
(9)
(33)
(16)
(8)
(10)
(8)
(11)
(13)
(14)
(21)
(10)
(15)
(8)
(8)
(12)
(8)
(15)
(12)
(18)
(9)
(12)
(13)
(13)
(23)
(11)
(15)
(11)
(9)
(8)
(8)
(13)
(25)
(13)
(17)
(8)
(13)
(11)
(13)
(11)
(9)
(10)
(8)
(10)
(21)
(13)
(21)
(23)
(25)
(8)
(9)
(11)
(11)
(15)
(10)
(13)
(10)
(9)
(19)
(14)
(10)
0 of 1000
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(5)
(4)
(1)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(3)
(1)
(3)
(1)
(2)
(1)
(2)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(7)
(3)
(2)
(3)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(8)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(13)
(1)
(1)
(7)
(1)
(16)
(14)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(33)
(1)
(2)
(106)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(4)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(6)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(2)
(68)
(1)
(4)
(1)
(1)
(1)
(1)
(2)
(2)
(4)
(1)
(1)
(1)
(8)
(4)
(1)
(3)
(6)
(5)
(2)
(1)
(11)
(1)
(2)
(3)
(1)
(7)
(1)
(4)
(1)
(1)
(1)
(3)
(1)
(6)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(12)
(1)
(3)
(1)
(1)
(3)
(1)
(1)
(116)
(1)
(2)
(1)
(1)
(4)
(22)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3941)
(6)
(1)
(1)
(2)
(11)
(10)
(1)
(1)
(41)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(14)
(1)
(1)
(1)
(4)
(20)
(1)
(7)
(3)
(1)
(1)
(1)
(3)
(1)
(1)
(5)
(1)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(3)
(13)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(7)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(65)
(3)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(3)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(10)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(33)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(21)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(3)
(3)
(1)
(1)
(1)
(1)
(425)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(6)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(13)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(3)
(2)
(2)
(2)
(4)
(3)
(3)
(4)
(2)
(5)
(1)
(2)
(3)
(2)
(3)
(9)
(2)
(2)
(2)
(2)
(9)
(2)
(7)
(4)
(2)
(2)
(5)
(2)
(12)
(12)
(2)
(7)
(4)
(2)
(3)
(2)
(3)
(4)
(4)
(2)
(5)
(7)
(4)
(2)
(5)
(7)
(2)
(9)
(2)
(2)
(8)
(2)
(2)
(2)
(4)
(9)
(3)
(3)
(2)
(2)
(5)
(9)
(4)
(4)
(2)
(2)
(5)
(4)
(2)
(3)
(3)
(9)
(4)
(4)
(6)
(4)
(2)
(3)
(2)
(6)
(2)
(11)
(2)
(3)
(2)
(2)
(2)
(3)
(10)
(4)
(2)
(8)
(2)
(15)
(2)
(2)
(20)
(2)
(3)
(6)
(2)
(2)
(5)
(2)
(13)
(11)
(2)
(24)
(2)
(3)
(3)
(7)
(2)
(3)
(3)
(3)
(2)
(9)
(2)
(14)
(2)
(7)
(3)
(4)
(3)
(2)
(3)
(9)
(5)
(9)
(50)
(8)
(3)
(13)
(3)
(3)
(2)
(4)
(3)
(9)
(5)
(3)
(2)
(2)
(2)
(15)
(9)
(5)
(4)
(2)
(5)
(4)
(5)
(4)
(5)
(5)
(11)
(4)
(12)
(5)
(2)
(2)
(7)
(5)
(3)
(2)
(5)
(2)
(2)
(3)
(2)
(3)
(2)
(2)
(149)
(7)
(2)
(2)
(3)
(3)
(3)
(3)
(2)
(6)
(2)
(3)
(3)
(10)
(2)
(16)
(2)
(7)
(9)
(6)
(4)
(7)
(5)
(4)
(11)
(3)
(4)
(13)
(17)
(2)
(24)
(2)
(2)
(4)
(8)
(7)
(11)
(8)
(5)
(3)
(13)
(4)
(17)
(6)
(9)
(2)
(22)
(2)
(2)
(6)
(3)
(9)
(3)
(2)
(4)
(15)
(3)
(4)
(3)
(8)
(15)
(6)
(2)
(23)
(2)
(2)
(4)
(5)
(5)
(24)
(2)
(4)
(2)
(7)
(2)
(2)
(9)
(3)
(2)
(9)
(6)
(11)
(5)
(15)
(4)
(2)
(3)
(5)
(6)
(2)
(118)
(5)
(18)
(3)
(2)
(7)
(125)
(2)
(3)
(2)
(5)
(7)
(2)
(3)
(2)
(4)
(6)
(6)
(3)
(3)
(2)
(3)
(2)
(10)
(12)
(4)
(2)
(3)
(3)
(4)
(9)
(2)
(2)
(2)
(5)
(6)
(4)
(2)
(2)
(13)
(2)
(4)
(2)
(2)
(2)
(4)
(3)
(9)
(2)
(4)
(2)
(2)
(2)
(7)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(4)
(3)
(3)
(3)
(4)
(12)
(4)
(2)
(5)
(6)
(5)
(2)
(3)
(14)
(4)
(2)
(2)
(2)
(2)
(2)
(14)
(7)
(7)
(3)
(2)
(3)
(2)
(2)
(2)
(44)
(183)
(2)
(88)
(115)
(2)
(8)
(16)
(10)
(5)
(2)
(14)
(180)
(2)
(3)
(3)
(6)
(93)
(2)
(2)
(2)
(4)
(317)
(7)
(11)
(2)
(6)
(8)
(2)
(3)
(26)
(80)
(2)
(2)
(22)
(3)
(2)
(36)
(30)
(10)
(4)
(3)
(6)
(2)
(3)
(4)
(3)
(2)
(4)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(2)
(2)
(4)
(2)
(2)
(4)
(2)
(3)
(2)
(2)
(2)
(2)
(4)
(3)
(2)
(5)
(2)
(2)
(4)
(2)
(2)
(2)
(4)
(15)
(3)
(3)
(2)
(14)
(2)
(2)
(6)
(15)
(13)
(4)
(2)
(3)
(5)
(2)
(2)
(5)
(8)
(2)
(4)
(2)
(3)
(2)
(3)
(7)
(2)
(2)
(4)
(4)
(2)
(4)
(2)
(2)
(2)
(2)
0 of 1000
(2)
(1)
(113)
(2)
(8)
(1)
(2910)
(5)
(2018)
(13)
(35)
(84)
(3)
(1)
(1)
(2)
(4)
(14)
(1)
(53)
(4075)
(2)
(4)
0 of 23
(1)
(2)
(15)
(33)
(13)
(1)
(8)
(2)
(2)
(4)
(5)
(25)
(1)
(7)
(2)
(180)
(1)
(113)
(2)
(3)
(7)
(1)
(3)
(10)
(11)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(14)
(168)
(159)
(1)
(1)
(1)
(1)
(20)
(1)
(28)
(1)
(2)
(23)
(2)
(1)
(1)
(1)
(1)
(1)
(23)
(8)
(1)
(2)
(3)
(1)
(6)
(1)
(19)
(1)
(7)
(2)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(3)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(12)
(1)
(1)
(1)
(2)
(1)
(16)
(1)
(1)
(3)
(1)
(20)
(1)
(5)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(4)
(1)
(2)
(2)
(2)
(1)
(871)
(2)
(1)
(11)
(1)
(3)
(6)
(1)
(1)
(1)
(87)
(4)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(3)
(2)
(1)
(1)
(14)
(3)
(53)
(1)
(4)
(1)
(1)
(1)
(8)
(17)
(1)
(1)
(1)
(1)
(7)
(1)
(8)
(266)
(1)
(7)
(1)
(1)
(3)
(201)
(2)
(2)
(1)
(1)
(4)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(2)
(2)
(39)
(1)
(14)
(13)
(1)
(5)
(1)
(2)
(11)
(1)
(1)
(177)
(2)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(4)
(1)
(7)
(1)
(1)
(1)
(4)
(68)
(1)
(1)
(1)
(1)
(1)
(1)
(12)
(39)
(2)
(1)
(1)
(5)
(3)
(12)
(315)
(1)
(1)
(1)
(1)
(28)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(468)
(3)
(6)
(42)
(3)
(12)
(5)
(1)
(4)
(10)
(1)
(1)
(20)
(1)
(8)
(1)
(1)
(1)
(3)
(2)
(15)
(14)
(8)
(2)
(18)
(1)
(112)
(1)
(1)
(1)
(1)
(4)
(5)
(24)
(1)
(1)
(9)
(3)
(76)
(1)
(307)
(1)
(1)
(1)
(31)
(161)
(12)
(1)
(174)
(3)
(3)
(10)
(7)
(25)
(1)
(1)
(1)
(4)
(23)
(42)
(1)
(1)
(1)
(1)
(111)
(1)
(1)
(1)
(1)
(213)
(18)
(1)
(1)
(9)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(7)
(4)
(1)
(1)
(1)
(1)
(4)
(32)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(13)
(3)
(96)
(1)
(1)
(2)
(4)
(5)
(209)
(1)
(2)
(3)
(1)
(1)
(127)
(9)
(7)
(3)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(204)
(1)
(1)
(272)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(55)
(1)
(1)
(1)
(1)
(1)
(5)
(265)
(12)
(5)
(3)
(11)
(1)
(8)
(3)
(1)
(1)
(1)
(3)
(1)
(306)
(3)
(1)
(131)
(2)
(1)
(163)
(1)
(1)
(1)
(77)
(4)
(3)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(2)
(1)
(3)
(1)
(2)
(3)
(3)
(112)
(1)
(1)
(9)
(2)
(27)
(34)
(2)
(1)
(1)
(3)
(1)
(18)
(1)
(5)
(3)
(3)
(60)
(1)
(237)
(2)
(1)
(187)
(2)
(1)
(5)
(1)
(500)
(1)
(6)
(2)
(16)
(1)
(7)
(5)
(156)
(1)
(1)
(1)
(6)
(3)
(9)
(4)
(31)
(1)
(1)
(4)
(1)
(248)
(1)
(45)
(1)
(2)
(4)
(10)
(8)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(558)
(114)
(1)
(1)
(4)
(10)
(1)
(1)
(267)
(1)
(57)
(80)
(241)
(256)
(318)
(52)
(45)
(51)
(88)
(72)
(1)
(1)
(1)
(1)
(1)
(3)
(6)
(8)
(31)
(8)
(7)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(300)
(1)
(1)
(13)
(10)
(2)
(27)
(1)
(1)
(1)
(1)
(1)
(18)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(19)
(1)
(1)
(1)
(5)
(16)
(1)
(2)
(1)
(154)
(1)
(1)
(1)
(5)
(1)
(9)
(1)
(1)
(3)
(2)
(1)
(90)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(5)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(3)
(11)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(3)
(3)
(1)
(4)
(1)
(4)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(18)
(13)
(1)
(14)
(1)
(1)
(13)
(11)
(1)
(2)
(1)
(116)
(46)
(8)
(2)
(1)
(4)
(9)
(4)
(20)
(1)
(2)
(2)
(1)
(5)
(2)
(1)
(2)
(1)
(14)
(1)
(1)
(1)
(1)
(2)
(2)
(22)
(24)
(1)
(1)
(1)
(3)
(1)
(18)
(1)
(1)
(10)
(1)
(1)
(1)
(1)
(1)
(185)
(1)
(1)
(481)
(22)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(11)
(8)
(1)
(1)
(1)
(7)
(1)
(1)
(130)
(1)
(24)
(1)
(1)
(67)
(7022)
(1)
(11)
(1)
(1)
(5)
(11)
(154)
(1)
(1)
(11)
(79)
(1)
(1)
(3)
(31)
(3)
(1)
(4)
(215)
(4)
(2)
(1)
(1)
(30)
(2)
(1)
(390)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(256)
(1)
(1)
(195)
(1)
(1)
(2)
(1)
(45)
(1)
(3)
(9)
(6)
(8)
(9)
(1)
0 of 772
(1)
(55)
(9)
(2)
(2)
(25)
(294)
(2)
(2)
(2)
(3)
(1)
(5)
(27)
(1)
(3)
(5)
(14)
(61)
(10)
(1)
(2)
(5)
(1)
(729)
(2)
(2776)
(5)
(5)
(37)
(1)
(15)
(1)
(7)
(3)
(16)
(27)
(1)
(108)
(2)
(383)
(52)
(1)
(1)
(1)
(1)
(2027)
(1)
(5)
(1)
(8)
(366)
(4)
(3)
(50)
(3)
0 of 56
(3)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(8)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(2)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(3)
(1)
(1)
(2)
(2)
(1)
(1)
(2)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
0 of 794
(82)
(4)
(1)
(6)
0 of 4
Showing 1301 - 1320 of 9537 results
  • Effectiveness of PfizerBioNTech and Moderna Vaccines in Preventing SARSCoV2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARSCoV2 B16172 Delta Variants National Healthcare Safety Network March 1August 1 2021
    Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variants — National Healthcare Safety Network, March 1–August 1, 2021
    Nanduri, Srinivas ;
    Pilishvili, Tamara
    August 18, 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    What is already known about this topic? Early observational studies among nursing home residents showed mRNA vaccines to be 53% to 92% effective against SARS-CoV-2 infection.What is added by this report? Two doses of mRNA vaccines were 74.7% effective against infection among nursing home residents early in the vaccination program (March–May 2021). ...
    Supporting Files Public Domain
  • New COVID19 Cases and Hospitalizations Among Adults by Vaccination Status New York May 3July 25 2021
    New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status — New York, May 3–July 25, 2021
    Rosenberg, Eli S. ;
    Holtgrave, David R.
    August 18, 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    What is already known about this topic? Real-world studies of population-level vaccine effectiveness against laboratory-confirmed SARS-CoV-2 infection and COVID-19 hospitalizations are limited in the United StatesWhat is added by this report? During May 3–July 25, 2021, the overall age-adjusted vaccine effectiveness against hospitalization in New Y ...
    Supporting Files Public Domain
  • Sustained Effectiveness of PfizerBioNTech and Moderna Vaccines Against COVID19 Associated Hospitalizations Among Adults United States MarchJuly 2021
    Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021
    Tenforde, Mark W. ;
    Self, Wesley H.
    August 18, 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    What is already known about this topic? COVID-19 mRNA vaccines provide strong protection against severe COVID-19; however, the duration of protection is uncertain.What is added by this report? Among 1,129 patients who received 2 doses of a mRNA vaccine, no decline in vaccine effectiveness against COVID-19 hospitalization was observed over 24 weeks. ...
    Supporting Files Public Domain
  • West Nile Virus and Other Domestic Nationally Notifiable Arboviral Diseases United States 2019
    West Nile Virus and Other Domestic Nationally Notifiable Arboviral Diseases — United States, 2019
    Vahey, Grace M. ;
    Mathis, Sarabeth
    8 13 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Arthropod-borne Viruses (arboViruses) are transmitted to humans primarily through the bites of infected mosquitoes and ticks. West Nile Virus (WNV) is the leading cause of domestically acquired arboviral disease in the United States (1). Other arboViruses, including La Crosse, Jamestown Canyon, Powassan, eastern equine encephalitis, and St. Louis e ...
    Supporting Files Public Domain
  • Erratum Vol 70 No 29
    Erratum: Vol. 70, No. 29
    8 13 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Erratum for: SchrammPJ, VaidyanathanA, RadhakrishnanL, GatesA, HartnettK, BreysseP. Heat-related emergency department visits during the northwestern heat wave—United States, June 2021.MMWR Morb Mortal Wkly Rep2021;70:1020–1. 10.15585/mmwr.mm7029e1This corrects the article "Heat-Related Emergency Department Visits During the Northwestern Heat Wave — ...
    Supporting Files Public Domain
  • Reduced Risk of Reinfection with SARSCoV2 After COVID19 Vaccination Kentucky MayJune 2021
    Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021
    Cavanaugh, Alyson M. ;
    Spicer, Kevin B.
    8 13 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Although laboratory evidence suggests that antibody responses following COVID-19 vaccination provide better neutralization of some circulating Variantss than does natural infection (1,2), few real-world epidemiologic studies exist to support the benefit of vaccination for previously infected persons. This report details the findings of a case-contr ...
    Supporting Files Public Domain
  • Effectiveness of COVID19 Vaccines in Preventing Hospitalization Among Adults Aged 65 Years COVIDNET 13 States FebruaryApril 2021
    Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years — COVID-NET, 13 States, February–April 2021
    Moline, Heidi L. ;
    Whitaker, Michael
    8 13 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Clinical trials of COVID-19 vaccines currently authorized for emergency use in the United States (Pfizer-BioNTech, Moderna, and Janssen [Johnson & Johnson]) indicate that these vaccines have high efficacy against symptomatic disease, including moderate to severe illness (1-3). In addition to clinical trials, real-world assessments of COVID-19 vacci ...
    Supporting Files Public Domain
  • Use of COVID19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen Johnson Johnson and mRNA COVID19 Vaccines PfizerBioNTech and Moderna Update from the Advisory Committee on Immunization Practices United States July 2021
    Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021
    Rosenblum, Hannah G. ;
    Hadler, Stephen C.
    8 13 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    In December 2020, the Food and Drug Administration (FDA) issued Emergency Use Authorizations (EUAs) for Pfizer-BioNTech and Moderna Covid-19 Vaccines, and in February 2021, FDA issued an EUA for the Janssen (Johnson & Johnson) COVID-19 vaccine. After each EUA, the Advisory Committee on Immunization Practices (ACIP) issued interim recommendations fo ...
    Supporting Files Public Domain
  • QuickStats Percentage of Adults Aged 18 Years Who Daily Experienced Feelings of Anxiety Feeling Worried Nervous Or Anxious Or Depression Or Both by Sex National Health Interview Survey United States 2019
    QuickStats: Percentage of Adults Aged ≥18 Years Who Daily Experienced Feelings of Anxiety (Feeling Worried, Nervous, Or Anxious) Or Depression, Or Both, by Sex — National Health Interview Survey, United States, 2019
    Ng, Amanda E. ;
    Black, Lindsey I.
    8 13 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    In 2019, women were more likely than men to feel worried, nervous, or anxious on a daily basis (15.0% versus 10.2%). Women were also more likely to feel depressed daily (4.9%) compared with men (3.5%). A higher percentage of women than men reported experiencing daily feelings of both anxiety and depression (3.9% versus 2.6%).Source: National Center ...
    Supporting Files Public Domain
  • Alternative Methods for Grouping Race and Ethnicity to Monitor COVID19 Outcomes and Vaccination Coverage
    Alternative Methods for Grouping Race and Ethnicity to Monitor COVID-19 Outcomes and Vaccination Coverage
    Yoon, Paula ;
    Hall, Jeffrey
    8 13 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Population-based analyses of COVID-19 data, by race and ethnicity can identify and monitor disparities in COVID-19 outcomes and vaccination coverage. CDC recommends that information about race and ethnicity be collected to identify disparities and ensure equitable access to protective measures such as vaccines; however, this information is often mi ...
    Supporting Files Public Domain
  • Supplementary Figures 1 and 2 For Sustained Effectiveness of PfizerBioNTech and Moderna Vaccines Against COVID19 Associated Hospitalizations Among Adults United States MarchJuly 2021
    Supplementary Figures 1 and 2 For: Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021
    Centers for Disease Control and Prevention (U.S.)
    08/13/2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Supplmentary figures for: Tenforde MW, Self WH, Naioti EA, et al. Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021. MMWR Morb Mortal Wkly Rep 2021;70:1156-1162.
    Public Domain
  • MMWR Morbidity and Mortality Weekly Report Vol 70 No 32 August 13 2021
    MMWR. Morbidity and Mortality Weekly Report, Vol. 70, No. 32, August 13, 2021
    Centers for Disease Control and Prevention (U.S.)
    August 13, 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    West Nile Virus and Other Domestic Nationally Notifiable Arboviral Diseases — United States, 2019Alternative Methods for Grouping Race and Ethnicity to Monitor COVID-19 Outcomes and Vaccination CoverageReduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021Rapid Increase in Circulation of the SARS-CoV-2 B.1. ...
    Public Domain
  • Notes From the Field Recurrence of a Multistate Outbreak of Salmonella Typhimurium Infections Linked to Contact with Hedgehogs United States and Canada 2020
    Notes From the Field: Recurrence of a Multistate Outbreak of Salmonella Typhimurium Infections Linked to Contact with Hedgehogs — United States and Canada, 2020
    Waltenburg, Michelle A. ;
    Nichols, Megin
    8 13 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Supporting Files Public Domain
  • Weeks ending log 20212022 MMWR weeks
    Weeks ending log 2021-2022 [MMWR weeks]
    Centers for Disease Control and Prevention (U.S.)
    2021/08/12 | MMWR weeks
    The MMWR week is the week of the epidemiologic year for which the National Notifiable Diseases Surveillance System (NNDSS) disease report is assigned by the reporting local or state health department for the purposes of MMWR disease incidence reporting and publishing. Values for MMWR week range from 1 to 53, although most years consist of 52 weeks. ...
    Public Domain
  • Use of COVID19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen Johnson Johnson and MRNA COVID19 Vaccines PfizerBioNTech and Moderna Update From the Advisory Committee on Immunization Practices United States July 2021
    Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and MRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update From the Advisory Committee on Immunization Practices — United States, July 2021
    Rosenblum, Hannah G. ;
    Hadler, Stephen C.
    August 10, 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    What is already known about this topic? Rare serious adverse events have been reported after COVID-19 vaccination, including Guillain-Barré syndrome (GBS) and thrombosis with thrombocytopenia syndrome (TTS) after Janssen COVID-19 vaccination and myocarditis after mRNA (Pfizer-BioNTech and Moderna) COVID-19 vaccination.What is added by this report? ...
    Supporting Files Public Domain
  • Erratum Vol 70 No 15
    Erratum: Vol. 70, No. 15
    8 06 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    This corrects the article "Progress in Immunization Safety Monitoring — Worldwide, 2010–2019" on page 547.In the report, “Progress in Immunization Safety Monitoring — Worldwide, 2010–2019,” in the figure on p. 548 (Figure 1), six countries were depicted on the map as having data sources “not available,” but should have been depicted as having the f ...
    Supporting Files Public Domain
  • Rapid Increase in Circulation of the SARSCoV2 B16172 Delta Variants Mesa County Colorado AprilJune 2021
    Rapid Increase in Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variants — Mesa County, Colorado, April–June 2021
    Herlihy, Rachel ;
    Bamberg, Wendy
    August 6, 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    What is already known about this topic? The highly transmissible B.1.617.2 (Delta) Variants of SARS-CoV-2 has become the predominant circulating U.S. strain.What is added by this report? During April–June 2021, COVID-19 cases caused by the Delta Variants increased rapidly in Mesa County, Colorado. Compared with that in other Colorado counties, inci ...
    Supporting Files Multi-Language Public Domain
  • Outbreak of SARSCoV2 Infections Including COVID19 Vaccine Breakthrough Infections Associated with Large Public Gatherings Barnstable County Massachusetts July 2021
    Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021
    Arvidson, Deirdre ;
    Brock-Fisher, Taylor
    2021/08/06 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    What is already known about this topic? Variants of SARS-CoV-2 continue to emerge. The B.1.617.2 (Delta) variant is highly transmissible. What is added by this report? In July 2021, following multiple large public events in a Barnstable County, Massachusetts, town, 469 COVID-19 cases were identified among Massachusetts residents who had traveled to ...
    Supporting Files Public Domain
  • QuickStats Injury Deaths As a Percentage of Total Deaths by Age Group National Vital Statistics System US United States 2019
    QuickStats: Injury Deaths As a Percentage of Total Deaths, by Age Group — National Vital Statistics System (U.S.), United States, 2019
    Hedegaard, Holly ;
    Garnett, Matthew F.
    8 06 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Injuries accounted for the majority of deaths among persons aged 15–39 years, with the highest percentages among those aged 15–19 (76.0%) and 20–24 years (78.2%). The percentage of injury deaths was lowest among those aged <1 year (7.9%), 60–64 years (7.5%), and ≥65 years (3.4%).Source: National Center for Health Statistics, National Vital Statistics System (U.S.), Mortality Data, 2019. https://www.cdc.gov/nchs/nvss/deaths.htmReported by: Holly Hedegaard, MD; Matthew F. Garnett, MPH; Merianne R. Spencer, MPH.
    Supporting Files Public Domain
  • COVID19 Vaccine Safety in Adolescents Aged 1217 Years United States December 14 2020July 16 2021
    COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020–July 16, 2021
    Hause, Anne M. ;
    Gee, Julianne
    8 06 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    As of July 30, 2021, among the three COVID-19 vaccines authorized for use in the United States, only the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine is authorized for adolescents aged 12-17 years. The Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for Pfizer-BioNTech vaccine for use in persons aged ≥16 years on De ...
    Supporting Files Public Domain
1301 - 1320 / 9537
 Was this page helpful?
 Found an issue?
Send us an email at: publishinghd@cdc.gov